The cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improve when ...

"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

According to DelveInsight’s analysis, the human papillomavirus market is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies and healthcare ...

In order to one day eliminate cervical cancer, the World Health Organization has set out a global strategy: 90 percent of girls to be vaccinated by the age of 15; 70 percent of women screened by the ...

According to a report, nine types of Human papillomavirus (HPV) are accountable for almost 98.4 per cent of total cervical ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This cohort of women is the first to be widely protected against cervical ...

Although thought of as a disease of middle age, cervical cancer sometimes kills young women as well – but vaccination has ...

The Pune Municipal Corporation has partnered with NGOs to vaccinate young girls in municipal schools against HPV infection, aiming to prevent cervical cancer.

Women are being urged to come forward for cervical screening as new figures show more than five million are not up to date with their routine check-ups. The NHS invites women for screening every three ...

This study found a steep decline in cervical cancer mortality among U.S. women younger than 25 years between 2016 and 2021. This ...